Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent

L Fernández1, J Valentín2, M Zalacain3

  • 1Clinical Research Department, Spanish National Cancer Research Centre CNIO, C/Melchor Fernández Almagro, 3, 28029 Madrid, Spain.

Cancer Letters
|August 16, 2015
PubMed

Insights

Natural killer (NK) cells effectively eliminate osteosarcoma (OS) cells, including treatment-resistant tumor-initiating cells (TICs). Spironolactone enhances NK cell therapy efficacy against bone cancer.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Metastatic and recurrent bone cancer, particularly osteosarcoma (OS), remains difficult to treat with current therapies.
  • Tumor-initiating cells (TICs) drive chemotherapy resistance, recurrence, and metastasis in OS.
  • Natural killer (NK) cells are crucial for innate immunity and possess anti-tumor properties.

Purpose of the Study:

  • To investigate the efficacy of activated and expanded NK (NKAE) cells in eliminating osteosarcoma (OS) cells and OS tumor-initiating cells (TICs).
  • To elucidate the molecular pathways involved in NK cell-mediated OS cell lysis.
  • To evaluate the potential of spironolactone (SPIR) in enhancing NK cell therapy for OS.

Main Methods:

  • Flow cytometry to assess NK cell receptor ligand expression on OS cells and NKAE cell targeting of OS TICs.
  • In vitro cytotoxicity assays of NKAE cells against OS cells.
  • Antibody blockade to explore NK cell-mediated lysis pathways.
  • Sphere formation assays to analyze NKAE cell targeting of OS TICs.
  • In vitro and in vivo studies of spironolactone's effect on OS cell susceptibility to NK cell lysis.

Main Results:

  • Osteosarcoma cells are susceptible to lysis by NKAE cells both in vitro and in vivo.
  • NKAE cell-mediated cytotoxicity relies on the interaction between the NKG2D receptor and NKG2D ligands (NKGKL).
  • Spironolactone enhances OS cell susceptibility to NKAE cell lysis and reduces OS TICs.
  • NKAE cells effectively target the OS TICs compartment.

Conclusions:

  • NKAE cells demonstrate significant potential in targeting and eliminating osteosarcoma cells, including TICs.
  • The NKG2D/NKG2DL pathway is critical for NK cell-mediated osteosarcoma cell killing.
  • Spironolactone can augment NK-cell based immunotherapy by increasing cancer cell susceptibility to NK cell-mediated lysis, offering a promising therapeutic strategy for osteosarcoma.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
10.6K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K